Johnson & Johnson is buying hair care products maker Vogue International for about $3.3 billion.
Privately-held Vogue also sells other personal care products.
The acquisition will give Johnson & Johnson the OGX collection of shampoos, conditioners, treatments, styling products, body care and bath products, the FX hair styling product line and the Proganix and Maui Moisture hair care lines.
Vogue’s hair care products are sold in the U.S. and 38 other countries.
Johnson & Johnson, based in New Brunswick, N.J., has brands including Neutrogena and Band-Aid.
The deal is expected to close in the third quarter.
Johnson & Johnson said that the transaction isn’t expected to impact its previously announced full-year sales and earnings forecasts.
J&J shares rose 47 cents to $113.25 in morning trading Thursday. Its shares are up more than 13 percent over the past year.
Source: Associated Press via Salt Lake Tribune
The United Arab Emirates (UAE) Ministry of Health and Prevention (MoHAP) has established a partnership with Novo Nordisk Pharma Gulf focusing on the creation of a national scientific guide for obesity management and weight control. The collaboration also aims to enhance public awareness of cardiovascular diseases and their complications.
Pharma giant Eli Lilly is teaming up with Haya Therapeutics in a $1bn deal to find multiple regulatory-genome-derived RNA-based drug targets, as it eyes up new targets in obesity. Under the deal, the companies will use Haya’s proprietary regulatory genome discovery platform to identify and validate long non-coding RNA (lncRNA) targets for developing potential treatments for obesity and related metabolic disorders.
The sale includes custom formulation and contract manufacturing capabilities for the nutrition market from the production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico. Financial terms of the transaction were not disclosed.
